参考文献/References:
[1]BosséY.Genetics of chronic obstructive pulmonary disease:asuccinct review,future avenues and prospective clinical applications[J].Pharmacogenomics,2009,10(4):655-667.
[2]Alam S,Li Z,Atkinson C,et al.Z α1-antitrypsin confers a proin-flammatory phenotype that contributes to chronic obstructive pulmonarydisease [J].Am J RespirCrit Care Med,2014,189(8):903-931.
[3]Ganrot P O,Laurell C B,ErikssonS.Obstructive lung disease and trypsininhibitorsi in alpha-1-antitrypsin deficiency[J].Scand J Clin Lab Invest,1967,19(3):205-208.
[4]de Serres F J,Blanco I,Fernandez BustilloE.Estimating the risk for alpha-1 antitryps in defteiency among COPD patients:evidence supporting targeted screening[J].CO-PD,2006,3(3):133-139.
[5]李黎,邬超,王怀振,等.维吾尔族饲鸽者肺IFN-γ及IL-4 基因多态性研究 [J].现代生物医学进展现代生物医学进展,2015, 36(013):45-66.
[6]裘海燕,张伟.a1-AT、TNF-a、CYP450的多态性与COPD易感性的研究进展[J]实用临床医学,2013,14(1):131-133.
[7]Serres F,Blanco I.Role of alpha‐1 antitrypsin in human health and disease[J].Journal of Internal Medicine,2014,276(4):311.
[8]王震,梅晓冬.α1抗胰蛋白酶与慢性阻塞性肺疾病的研究进展[J].安徽医药,2011,15(1):113-114.
[9]张彦,贺蓓,赵鸣武,等.慢性阻塞性肺病患者α1抗胰蛋白酶的研究[J]中华医学杂志,2005,85(18):1270-1273.
[10]晁栋,李明,高炜,等.α1抗胰蛋白酶基因多态性与肺癌易感性的研究[J]医学研究杂志,2015,44(8):103-107.
[11]庞国菊,刘怀平.血清α1- 抗胰蛋白酶和 C 反应蛋白水平与慢性阻塞性肺疾病的相关性研究 [J].检验医学,2013,28(10):882-884.
[12]刘羽翔,杨汀,叶艳平,等.慢性阻塞性肺疾病稳定期患者血清α1-抗胰蛋白酶与气道炎症及肺功能的相关性研究[J].首都医科大学学报,2006,27(1):35-37.
[13]邱洁,张雅囡,陈娟,等.宁夏地区慢性阻塞性肺疾病血清α1-抗胰蛋白酶检测分析[J].中国现代医学杂志,2012,22(17):58-61.